Finance

Lists
KAEF:IDX
Kimia Farma Tbk PT
IDR 464.00
+1.75%
(+8.00) 1D
Aug 6, 4:12:57 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KAEF...
Open
IDR 462
High
IDR 488
Low
IDR 462
Mkt. cap
2.58T
Avg. vol.
768.72K
Volume
1.19M
52-wk high
IDR 785
52-wk low
IDR 380
EPS
-IDR 64
Shares outstanding
5.57B
No. of employees
10K
Open
IDR 462
High
IDR 488
Low
IDR 462
Mkt. cap
2.58T
Avg. vol.
768.72K
Volume
1.19M
52-wk high
IDR 785
52-wk low
IDR 380
EPS
-IDR 64
Shares outstanding
5.57B
No. of employees
10K
News stories
From sources across the web
Profile
PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta. Wikipedia
About Kimia Farma Tbk PT
CEO-
Employees9.57K
FoundedAug 16, 1971
Headquarters-
SectorPharmaceutical industry
Websitekimiafarma.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.64T
2.22T
2.03T
2.67T
Cost of goods sold
1.85T
1.56T
1.29T
1.74T
Cost of revenue
1.85T
1.56T
1.29T
1.74T
Research and development expenses
5.03B
7.54B
3.20B
-3.20B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
709.79B
663.87B
640.94B
921.74B
Operating expense
766.80B
877.17B
669.20B
850.96B
Total operating expenses
2.62T
2.44T
1.96T
2.59T
Operating income
23.59B
-222.99B
67.93B
83.93B
Other non operating income
-2.92B
173.66B
159.00B
-7.46B
EBT including unusual items
-94.33B
-223.75B
127.96B
-60.16B
EBT excluding unusual items
-93.48B
-260.76B
127.95B
-60.16B
Income tax expense
4.17B
-14.50B
4.32B
9.40B
Effective tax rate
-4.42%
6.48%
3.37%
-15.62%
Other operating expenses
-37.43B
-36.20B
-12.78B
-29.73B
Net income
-84.72B
-155.23B
74.45B
-64.12B
Net profit margin
-3.21%
-7.01%
3.67%
-2.40%
Earnings per share
-
-
-
-
Interest and investment income
2.65B
10.77B
2.87B
-
Interest expense
-115.65B
-221.53B
-110.15B
-128.68B
Net interest expenses
-112.99B
-210.75B
-107.28B
-128.68B
Depreciation and amortization charges
89.41B
175.98B
37.85B
-37.85B
EBITDA
105.34B
-86.40B
125.64B
141.64B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps